Wednesday , January 17 2018
Home / Letter From The Editor / Jan. 3, 2018

Jan. 3, 2018

Now that we are in the new year our patients will have every good intention on changing everything to make this their best and healthiest year ever. They will try a new exercise program and a new diet. They will swear they will take their medications and fix their glucose, hypertension and cholesterol values.

Making progress with hypertension and diabetes has been made easier with recent addition of be medications, but when it came to cholesterol until the advent of the PCSK9 Inhibitors there was not much in the way of new help.

This week Dr. Ray Kausik discusses the inside story on this new class of cholesterol lowering medications.

Dave Joffe

Editor-in-chief